Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

ILC1-like cells can independently cause alopecia areata.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.

The treatment using a special hydrogel shows promise for promoting hair growth.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

ITK inhibitors may effectively treat alopecia areata.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Blocking LFA-1 prevents hair loss in mice.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.